CN Patent

CN101222914A — 包含抗病毒药组合的稳定的固定剂量的制剂及使用干法制粒制备该制剂的方法

Assigned to Gilead Sciences Inc · Expires 2008-07-16 · 18y expired

What this patent protects

本发明针对含有经干法粒化的替诺福韦DF和恩曲他滨的组合物及其制备方法。干法制粒被出乎意料地发现对于制备含有替诺福韦DF的组合物是至关重要的，其中该组合物适于包含在含有恩曲他滨、依法韦仑和替诺福韦DF的组合剂型中。

USPTO Abstract

本发明针对含有经干法粒化的替诺福韦DF和恩曲他滨的组合物及其制备方法。干法制粒被出乎意料地发现对于制备含有替诺福韦DF的组合物是至关重要的，其中该组合物适于包含在含有恩曲他滨、依法韦仑和替诺福韦DF的组合剂型中。

Drugs covered by this patent

Patent Metadata

Patent number
CN101222914A
Jurisdiction
CN
Classification
—
Expires
2008-07-16
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.